Promethium Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.16M Buy
17,481
+48
+0.3% +$14.3K 2.67% 8
2025
Q4
$4.76M Buy
17,433
+1,305
+8% +$355K 2.57% 7
2025
Q3
$4.36M Buy
16,128
+619
+4% +$168K 2.5% 8
2025
Q2
$4.27M Buy
15,509
+534
+4% +$145K 2.6% 4
2025
Q1
$3.97M Buy
14,975
+2,726
+22% +$672K 2.54% 6
2024
Q4
$2.92M Buy
12,249
+456
+4% +$105K 2% 13
2024
Q3
$2.6M Buy
+11,793
New +$2.44M 1.84% 12

Other funds holding CME

Promethium Advisors's CME Position: Q1 2026 in Review

Promethium Advisors increased its CME Group (CME) stake by 0.28% in Q1 2026, buying an estimated $14.3K and bringing the position to 17,481 shares worth $5.16M. The position accounts for 2.67% of the portfolio, ranked #8.

Promethium Advisors first reported a position in CME in Q3 2024 and has held it in 7 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Promethium Advisors held 17,481 shares of CME Group worth $5.16M as of Q1 2026.
  • Promethium Advisors bought 48 CME Group shares in Q1 2026, an estimated $14.3K.
  • CME Group made up 2.67% of Promethium Advisors's portfolio in Q1 2026, its #8 holding.
  • Promethium Advisors first reported a position in CME Group in Q3 2024 and has held it in 7 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.